Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

UR1001

Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases/100 cores
Unstained: $345.00 Add to Cart
Trial (UR1001t*): $105.00 Add to Cart
H&E (UR1001s*): $345.00 Add to Cart

Microarray Panel:Ureter and urethra disease spectrum tissue microarray, containing 5 cases of squamous cell carcinoma, 2 adenocarcinoma, 16 transitional cell carcinoma, 1 carcinoma in situ, 4 hyperplasia, 10 inflammation, 8 adjacent normal tissue and 6 normal tissue, duplicate cores per case
Cores:100
Cases:50
Layout:10 cols × 10 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
B Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
C Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
D Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
E Ure Ure Ure Ure Bla Bla Ure Ure Ure Ure  
F Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
G Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
H Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
I Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure  
J Ure Ure Ure Ure Ure Ure Ure Ure Ure Ure Marked point
Legend: Bla - Bladder, Ure - Ureter

- Hyperplasia, - Inflammation, - Malignant tumor, - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IV), - Malignant tumor (stage Ois), - NAT, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 58 Urethra Squamous cell carcinoma 1 III T3N0M0 Malignant
A2 2 M 58 Urethra Squamous cell carcinoma 1 III T3N0M0 Malignant
A3 3 F 46 Urethra Squamous cell carcinoma 2 III T3N0M0 Malignant
A4 4 F 46 Urethra Squamous cell carcinoma 2 III T3N0M0 Malignant
A5 5 F 80 Urethra Squamous cell carcinoma 3 III T3N0M0 Malignant
A6 6 F 80 Urethra Squamous cell carcinoma 3 III T3N0M0 Malignant
A7 7 F 48 Urethra Papillary adenocarcinoma 2 II T2N0M0 Malignant
A8 8 F 48 Urethra Papillary adenocarcinoma 2 II T2N0M0 Malignant
A9 9 F 45 Urethra Adenocarcinoma 2 II T2N0M0 Malignant
A10 10 F 45 Urethra Adenocarcinoma 2 II T2N0M0 Malignant
B1 11 F 57 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
B2 12 F 57 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
B3 13 F 64 Ureter Transitional cell carcinoma 1 II T2N0M0 Malignant
B4 14 F 64 Ureter Transitional cell carcinoma 1 II T2N0M0 Malignant
B5 15 F 69 Ureter Transitional cell carcinoma 2 III T3N0M0 Malignant
B6 16 F 69 Ureter Transitional cell carcinoma 2 III T3N0M0 Malignant
B7 17 M 70 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
B8 18 M 70 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
B9 19 M 47 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
B10 20 M 47 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
C1 21 M 81 Urethra Transitional cell carcinoma 2–3 II T2N0M0 Malignant
C2 22 M 81 Urethra Transitional cell carcinoma 2–3 II T2N0M0 Malignant
C3 23 M 82 Ureter Transitional cell carcinoma (smooth muscle tissue) – III T3N0M0 Malignant
C4 24 M 82 Ureter Transitional cell carcinoma 2 III T3N0M0 Malignant
C5 25 M 68 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
C6 26 M 68 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
C7 27 M 82 Urethra Transitional cell carcinoma 2 II T2N0M0 Malignant
C8 28 M 82 Urethra Transitional cell carcinoma 2 II T2N0M0 Malignant
C9 29 M 46 Ureter Transitional cell carcinoma 2 II T3N0M0 Malignant
C10 30 M 46 Ureter Transitional cell carcinoma 2 II T3N0M0 Malignant
D1 31 M 70 Ureter Transitional cell carcinoma 2 II T3N0M0 Malignant
D2 32 M 70 Ureter Transitional cell carcinoma 2 II T3N0M0 Malignant
D3 33 F 75 Ureter Transitional cell carcinoma 2 IV T4N0M0 Malignant
D4 34 F 75 Ureter Transitional cell carcinoma 2 IV T4N0M0 Malignant
D5 35 M 78 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
D6 36 M 78 Ureter Transitional cell carcinoma 2 II T2N0M0 Malignant
D7 37 F 68 Urethra Transitional cell carcinoma 3 III T3N0M0 Malignant
D8 38 F 68 Urethra Transitional cell carcinoma 3 III T3N0M0 Malignant
D9 39 M 67 Ureter Transitional cell carcinoma 3 II T2N0M0 Malignant
D10 40 M 67 Ureter Transitional cell carcinoma 3 II T2N0M0 Malignant
E1 41 M 38 Ureter Transitional cell carcinoma 3 III T3N0M0 Malignant
E2 42 M 38 Ureter Transitional cell carcinoma 3 III T3N0M0 Malignant
E3 43 F 67 Urethra Carcinoma in situ (hyperplasia of squamous epithelium) – Ois TisN0M0 Malignant
E4 44 F 67 Urethra Carcinoma in situ (hyperplasia of squamous epithelium) – Ois TisN0M0 Malignant
E5 45 M 52 Bladder Hyperplasia of transitional epithelium (sparse) – – – Hyperplasia
E6 46 M 52 Bladder Hyperplasia of transitional epithelium – – – Hyperplasia
E7 47 F 41 Ureter Chronic inflammation of mucosa with focal hyperplasia of transitional epithelium – – – Hyperplasia
E8 48 F 41 Ureter Mild hyperplasia of transitional epithelium – – – Hyperplasia
E9 49 M 78 Ureter Chronic inflammation with hyperplasia of transitional epithelium (sparse) – – – Hyperplasia
E10 50 M 78 Ureter Chronic inflammation with hyperplasia of transitional epithelium – – – Hyperplasia
F1 51 M 50 Ureter Chronic inflammation of mucosa with hyperplasia of transitional epithelium – – – Hyperplasia
F2 52 M 50 Ureter Chronic inflammation of mucosa with hyperplasia of transitional epithelium – – – Hyperplasia
F3 53 M 19 Ureter Chronic inflammation of mucosa (smooth muscle and blood vessel tissue) – – – Inflammation
F4 54 M 19 Ureter Chronic inflammation of mucosa (smooth muscle and blood vessel tissue) – – – Inflammation
F5 55 M 85 Ureter Chronic inflammation of mucosa – – – Inflammation
F6 56 M 85 Ureter Chronic inflammation of mucosa – – – Inflammation
F7 57 F 47 Ureter Chronic inflammation of mucosa – – – Inflammation
F8 58 F 47 Ureter Chronic inflammation of mucosa – – – Inflammation
F9 59 M 58 Ureter Chronic inflammation of mucosa – – – Inflammation
F10 60 M 58 Ureter Chronic inflammation of mucosa – – – Inflammation
G1 61 M 72 Ureter Chronic inflammation of mucosa – – – Inflammation
G2 62 M 72 Ureter Chronic inflammation of mucosa – – – Inflammation
G3 63 M 15 Ureter Chronic inflammation of mucosa – – – Inflammation
G4 64 M 15 Ureter Chronic inflammation of mucosa (smooth muscle tissue) – – – Inflammation
G5 65 M 72 Ureter Chronic inflammation of mucosa – – – Inflammation
G6 66 M 72 Ureter Chronic inflammation of mucosa – – – Inflammation
G7 67 M 67 Ureter Chronic inflammation of mucosa – – – Inflammation
G8 68 M 67 Ureter Chronic inflammation of mucosa – – – Inflammation
G9 69 M 64 Ureter Chronic inflammation of mucosa (smooth muscle tissue) – – – Inflammation
G10 70 M 64 Ureter Chronic inflammation of mucosa – – – Inflammation
H1 71 M 48 Ureter Chronic inflammation of mucosa – – – Inflammation
H2 72 M 48 Ureter Chronic inflammation of mucosa – – – Inflammation
H3 73 M 78 Ureter Cancer adjacent normal ureter tissue – – – NAT
H4 74 M 78 Ureter Cancer adjacent normal ureter tissue – – – NAT
H5 75 M 56 Ureter Cancer adjacent normal ureter tissue – – – NAT
H6 76 M 56 Ureter Cancer adjacent normal ureter tissue (smooth muscle tissue) – – – NAT
H7 77 F 37 Ureter Cancer adjacent normal ureter tissue – – – NAT
H8 78 F 37 Ureter Cancer adjacent normal ureter tissue (chronic inflammation of mucosa ) – – – NAT
H9 79 M 72 Ureter Cancer adjacent normal ureter tissue (sparse chronic inflammation of mucosa) – – – NAT
H10 80 M 72 Ureter Cancer adjacent normal ureter tissue (chronic inflammation of mucosa ) – – – NAT
I1 81 M 37 Ureter Cancer adjacent normal ureter tissue with mild hyperplasia – – – NAT
I2 82 M 37 Ureter Cancer adjacent normal ureter tissue (sparse) – – – NAT
I3 83 M 60 Ureter Cancer adjacent normal ureter tissue with focal hyperplasia of transitional epithelium – – – NAT
I4 84 M 60 Ureter Cancer adjacent normal ureter tissue with focal hyperplasia of transitional epithelium – – – NAT
I5 85 F 86 Ureter Cancer adjacent normal ureter tissue (chronic inflammation of mucosa ) – – – NAT
I6 86 F 86 Ureter Cancer adjacent normal ureter tissue (smooth muscle tissue) – – – NAT
I7 87 M 58 Ureter Cancer adjacent normal ureter tissue – – – NAT
I8 88 M 58 Ureter Cancer adjacent normal ureter tissue – – – NAT
I9 89 M 40 Ureter Normal ureter tissue – – – Normal
I10 90 M 40 Ureter Normal ureter tissue – – – Normal
J1 91 M 50 Ureter Normal ureter tissue (smooth muscle and blood vessel tissue) – – – Normal
J2 92 M 50 Ureter Normal ureter tissue (smooth muscle and blood vessel tissue) – – – Normal
J3 93 F 15 Ureter Normal ureter tissue (sparse) – – – Normal
J4 94 F 15 Ureter Normal ureter tissue – – – Normal
J5 95 M 45 Ureter Normal ureter tissue (fibrofatty tissue) – – – Normal
J6 96 M 45 Ureter Normal ureter tissue (blood vessel and fatty tissue) – – – Normal
J7 97 M 47 Ureter Normal ureter tissue – – – Normal
J8 98 M 47 Ureter Normal ureter tissue – – – Normal
J9 99 F 21 Ureter Normal ureter tissue (smooth muscle and blood vessel tissue) – – – Normal
J10 100 F 21 Ureter Normal ureter tissue (sparse) – – – Normal
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal